SYMDAZYME Trademark

Trademark Overview

On Thursday, March 7, 2019, a trademark application was filed for SYMDAZYME with the United States Patent and Trademark Office. The USPTO has given the SYMDAZYME trademark a serial number of 88329923. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 28, 2022. This trademark is owned by Genzyme Corporation. The SYMDAZYME trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of rare diseases; pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, viral and bacterial infections
symdazyme

General Information

Serial Number88329923
Word MarkSYMDAZYME
Filing DateThursday, March 7, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 28, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 3, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of rare diseases; pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, viral and bacterial infections

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 26, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGenzyme Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameGenzyme Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Monday, February 28, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 28, 2022ABANDONMENT - NO USE STATEMENT FILED
Friday, June 4, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 2, 2021SOU EXTENSION 3 GRANTED
Wednesday, June 2, 2021SOU EXTENSION 3 FILED
Wednesday, June 2, 2021SOU TEAS EXTENSION RECEIVED
Monday, December 14, 2020ASSIGNED TO EXAMINER
Wednesday, December 9, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 7, 2020SOU EXTENSION 2 GRANTED
Monday, December 7, 2020SOU EXTENSION 2 FILED
Monday, December 7, 2020SOU TEAS EXTENSION RECEIVED
Friday, July 3, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 1, 2020SOU EXTENSION 1 GRANTED
Wednesday, July 1, 2020SOU EXTENSION 1 FILED
Wednesday, July 1, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, January 28, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, January 8, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Tuesday, December 10, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 3, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 3, 2019PUBLISHED FOR OPPOSITION
Wednesday, November 13, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 30, 2019ASSIGNED TO LIE
Friday, October 25, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 22, 2019ASSIGNED TO EXAMINER
Thursday, September 26, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 25, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 25, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, April 13, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, April 13, 2019NON-FINAL ACTION E-MAILED
Saturday, April 13, 2019NON-FINAL ACTION WRITTEN
Sunday, March 31, 2019ASSIGNED TO EXAMINER
Tuesday, March 26, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 11, 2019NEW APPLICATION ENTERED

Related Keywords

symdazyme diseases preparations pharmaceutical treatment prevention namely infectious rare infections bacterial